Cargando…
Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1)
BACKGROUND: TGF-β(1) is a key cytokine involved in both airway inflammation and airway remodeling in asthma because of its anti-inflammatory and profibrotic effect. In our previous study, we found that knockdown of cytosolic β-catenin alleviated the profibrogenic effect of TGF-β(1) without influenci...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970683/ https://www.ncbi.nlm.nih.gov/pubmed/33530899 http://dx.doi.org/10.1177/1753466620981858 |
_version_ | 1783666460722200576 |
---|---|
author | Huo, Rujie Tian, Xinli Chang, Qin Liu, Dai Wang, Chen Bai, Jingcui Wang, Runjuan Zheng, Guoping Tian, Xinrui |
author_facet | Huo, Rujie Tian, Xinli Chang, Qin Liu, Dai Wang, Chen Bai, Jingcui Wang, Runjuan Zheng, Guoping Tian, Xinrui |
author_sort | Huo, Rujie |
collection | PubMed |
description | BACKGROUND: TGF-β(1) is a key cytokine involved in both airway inflammation and airway remodeling in asthma because of its anti-inflammatory and profibrotic effect. In our previous study, we found that knockdown of cytosolic β-catenin alleviated the profibrogenic effect of TGF-β(1) without influencing its anti-inflammatory effect. However, the exact role of targeting β-catenin in asthma is not yet fully demonstrated. In the present study, we investigated the effect and mechanism of targeting β-catenin in OVA-challenged asthmatic rats with airway inflammation and remodeling features. METHODS: We integrated experimental asthma model and asthma related cell model to explore the effect of targeting β-catenin on airway inflammation and remodeling of asthma. RESULTS: Blocking β-catenin with ICG001, a small molecule inhibitor of β-catenin/TCF via binding to cAMP-response elementbinding protein, attenuated airway inflammation by increasing levels of anti-inflammation cytokines IL-10, IL-35 and decreasing levels of T helper (Th)2 cells and Th17 cytokine. Suppressing β-catenin by ICG001 inhibited airway remodeling via reducing the level of TGF-β(1) and the expressions of Snail, MMP-7, MMP-9 and, up-regulating expression of E-cadherin, down-regulating expressions of α-SMA and Fn. Inhibition of β-catenin with ICG001 suppressed TGF-β(1) induced proliferation and activation of CCC-REPF-1, blocked TGF-β(1) induced epithelial–mesenchymal transition (EMT) of RLE-6TN. CONCLUSION: Blockade of β-catenin/TCF not only prevents TGF-β(1) induced EMT and profibrogenic effects involved in pathological remodeling of airway, but also alleviates airway inflammation in asthma by balancing pro-inflammatory and anti-inflammatory cytokine. In conclusion, targeting β-catenin specifically via inhibition of β-catenin/TCF might be a new therapeutic strategy for asthma. The reviews of this paper are available via the supplemental material section. |
format | Online Article Text |
id | pubmed-7970683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-79706832021-03-31 Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) Huo, Rujie Tian, Xinli Chang, Qin Liu, Dai Wang, Chen Bai, Jingcui Wang, Runjuan Zheng, Guoping Tian, Xinrui Ther Adv Respir Dis Original Research BACKGROUND: TGF-β(1) is a key cytokine involved in both airway inflammation and airway remodeling in asthma because of its anti-inflammatory and profibrotic effect. In our previous study, we found that knockdown of cytosolic β-catenin alleviated the profibrogenic effect of TGF-β(1) without influencing its anti-inflammatory effect. However, the exact role of targeting β-catenin in asthma is not yet fully demonstrated. In the present study, we investigated the effect and mechanism of targeting β-catenin in OVA-challenged asthmatic rats with airway inflammation and remodeling features. METHODS: We integrated experimental asthma model and asthma related cell model to explore the effect of targeting β-catenin on airway inflammation and remodeling of asthma. RESULTS: Blocking β-catenin with ICG001, a small molecule inhibitor of β-catenin/TCF via binding to cAMP-response elementbinding protein, attenuated airway inflammation by increasing levels of anti-inflammation cytokines IL-10, IL-35 and decreasing levels of T helper (Th)2 cells and Th17 cytokine. Suppressing β-catenin by ICG001 inhibited airway remodeling via reducing the level of TGF-β(1) and the expressions of Snail, MMP-7, MMP-9 and, up-regulating expression of E-cadherin, down-regulating expressions of α-SMA and Fn. Inhibition of β-catenin with ICG001 suppressed TGF-β(1) induced proliferation and activation of CCC-REPF-1, blocked TGF-β(1) induced epithelial–mesenchymal transition (EMT) of RLE-6TN. CONCLUSION: Blockade of β-catenin/TCF not only prevents TGF-β(1) induced EMT and profibrogenic effects involved in pathological remodeling of airway, but also alleviates airway inflammation in asthma by balancing pro-inflammatory and anti-inflammatory cytokine. In conclusion, targeting β-catenin specifically via inhibition of β-catenin/TCF might be a new therapeutic strategy for asthma. The reviews of this paper are available via the supplemental material section. SAGE Publications 2021-02-02 /pmc/articles/PMC7970683/ /pubmed/33530899 http://dx.doi.org/10.1177/1753466620981858 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Huo, Rujie Tian, Xinli Chang, Qin Liu, Dai Wang, Chen Bai, Jingcui Wang, Runjuan Zheng, Guoping Tian, Xinrui Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
title | Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
title_full | Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
title_fullStr | Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
title_full_unstemmed | Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
title_short | Targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
title_sort | targeted inhibition of β-catenin alleviates airway inflammation and remodeling in asthma via modulating the profibrotic and anti-inflammatory actions of transforming growth factor-β(1) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970683/ https://www.ncbi.nlm.nih.gov/pubmed/33530899 http://dx.doi.org/10.1177/1753466620981858 |
work_keys_str_mv | AT huorujie targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT tianxinli targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT changqin targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT liudai targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT wangchen targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT baijingcui targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT wangrunjuan targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT zhengguoping targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 AT tianxinrui targetedinhibitionofbcateninalleviatesairwayinflammationandremodelinginasthmaviamodulatingtheprofibroticandantiinflammatoryactionsoftransforminggrowthfactorb1 |